New drug combo targets Hard-to-Treat bone marrow disease
Disease control
Recruiting now
This early-stage study tests a new drug, SX-682, alone or with another drug (decitabine) in people with myelodysplastic syndrome (MDS), a bone marrow disorder. The main goal is to find a safe dose and check for side effects. About 151 adults whose disease has not responded to pri…
Phase: PHASE1 • Sponsor: Syntrix Biosystems, Inc. • Aim: Disease control
Last updated Apr 28, 2026 22:49 UTC